These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17066090)

  • 1. Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation.
    Maggini V; Buda G; Galimberti S; Conidi E; Giuliani N; Morabito F; Genestreti G; Iacopino P; Rizzoli V; Barale R; Petrini M; Rossi AM
    Leukemia; 2007 Jan; 21(1):176-8. PubMed ID: 17066090
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms.
    Maggini V; Buda G; Galimberti S; Conidi E; Giuliani N; Morabito F; Genestreti G; Iacopino P; Rizzoli V; Barale R; Petrini M; Rossi AM
    Leuk Res; 2008 Jan; 32(1):49-53. PubMed ID: 17512053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
    Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
    Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.
    Vesole DH; Simic A; Lazarus HM
    Bone Marrow Transplant; 2001 Oct; 28(8):725-35. PubMed ID: 11781623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
    Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
    Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.
    Patriarca F; Sperotto A; Filì C; Zaja F; Prosdocimo S; Fanin R
    Haematologica; 2002 Jul; 87(7):779-81. PubMed ID: 12091134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current therapy concepts in patients with multiple myeloma].
    Heyll A; Schneider P; Bauser U; Kobbe G; Hünerlitürkoglu A; Aul C; Haas R
    Dtsch Med Wochenschr; 2000 Oct; 125(40):1201-9. PubMed ID: 11075253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intensive treatment of multiple myeloma].
    Harousseau JL
    Bull Acad Natl Med; 2003; 187(2):405-13; discussion 413-5. PubMed ID: 14556449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
    van Rhee F
    Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
    [No Abstract]   [Full Text] [Related]  

  • 11. Tandem autologous stem cell transplantation in multiple myeloma after high-dose chemotherapy with two separate collections: single institution experience.
    Ladicka M; Ballova V; Drgona L; Vranovsky A; Lakota J
    Neoplasma; 2012; 59(5):551-8. PubMed ID: 22668021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
    Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
    Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide maintenance in multiple myeloma: certainties and controversies.
    Cavo M; Pantani L; Tacchetti P; Pallotti MC; Brioli A; Petrucci A; Zamagni E; Tosi P
    J Clin Oncol; 2009 Nov; 27(32):e186-7; author reply e188. PubMed ID: 19770366
    [No Abstract]   [Full Text] [Related]  

  • 14. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem autologous stem cell transplantation for multiple myeloma: is it applicable and effective outside clinical trials?
    Dimopoulos MA
    Haematologica; 2005 Dec; 90(12):1588. PubMed ID: 16330425
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the treatment of multiple myeloma.
    Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
    Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
    [No Abstract]   [Full Text] [Related]  

  • 17. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.
    Lemaire O; Attal M; Bourin P; Laroche M
    Eur J Haematol; 2010 Mar; 84(3):276-7. PubMed ID: 19891699
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
    Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
    Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.